Category: Expert Session
This project is funded by the European Regional Development Fund. This project is co-financed by the Agency for Innovation & Entrepreneurship and the province of West Flanders.
There’s a lot of talk about patient centricity in the clinical trial arena these days, and for good reason. Companies today are more open and do not view patients as mere “subjects” who generate data, – but as informed collaborators whose participation is “core” to the overall success of trials leading to the emergence of the concept of “patient-centric trials.”
But what does it mean to be patient centric, practically speaking? What tactics are leading pharma companies employing to make centricity a reality in their trials? What does patient centricity mean for your role? And what does it mean from a patient perspective?
This course is intended to provide an answer to these questions through lectures, practical lessons, workshops and a guided tour.
Who should attend
(Junior) CRA’s and Clinical Trial Managers who want to learn how to make patient centricity in clinical trials a reality.
Leave your e-mail address and receive an e-mail if a new date is known for this course. Your email address is not used for other purposes.
Policy Officer - Vlaams Patiëntenplatform
Founder - Akcelis
Co-Founder - Akcelis
CEO and founder - Esperity
Day 1: MeetingCentR4, Communicatiecampus, Sint-Denijslaan 487, 9000 Ghent, Belgium
Day 2: Clinical Pharmacology Unit Janssen, Lange Bremstraat 70, 2170 Antwerp, Belgium
150 euros (excl. VAT)
This course is part of the Clinical Testing theme of Helis Academy and is organised by flanders.bio and Vives. More info about other courses can be found on the website of the Helis Academy.